Malignant Spinal Cord Compression (MSCC) Management

Algorithm Steps

1. ▶

   Start

   Suspected Malignant Spinal Cord Compression

   Cancer patient with back pain + neurological symptoms

   1. ◆

      Decision

      Identify Red Flag Symptoms

      Urgent evaluation if any present

      • • New or progressive back/neck pain in cancer patient
      • • Thoracic back pain (highest risk)
      • • Pain worse lying down / night pain
      • • Leg weakness or difficulty walking
      • • Sensory changes: numbness, paresthesias
      • • Bladder/bowel dysfunction
      • • Saddle anesthesia
      1. ●

         Action

         Start Dexamethasone Immediately

         Do NOT wait for imaging if high suspicion

         • HIGH-DOSE: Dexamethasone 16-24mg IV bolus
         • Followed by: 16mg PO/IV daily (divided doses)
         • Alternative: 8mg BID or 4mg QID
         • Start PPI for GI prophylaxis
         • Monitor glucose (steroid-induced hyperglycemia)
         • Can give before MRI - don't delay for imaging
         1. ●

            Action

            Urgent MRI Whole Spine

            Within 24 hours, ideally <4 hours if neurological deficit

            • MRI of entire spine (multiple levels common)
            • T1, T2, and contrast-enhanced sequences
            • If MRI contraindicated: CT myelography
            • Assess: cord compression, vertebral collapse, instability
            • Contact radiology for urgent prioritization
            1. ◆

               Decision

               MSCC Confirmed on Imaging?

               Epidural disease with cord/cauda equina compression

               1. ●

                  Action

                  No Cord Compression

                  Alternative diagnosis or impending compression

                  • Continue steroids if significant epidural disease
                  • Urgent spine oncology review
                  • Consider prophylactic radiation
                  • Pain management
                  • Reassess if symptoms progress
                  1. ✓

                     Outcome

                     MSCC Treated - Continue Oncologic Care

                     Rehabilitation, systemic therapy, surveillance

               2. ◆

                  Decision

                  Neurological Status

                  Critical for prognosis and treatment selection

                  • AMBULATORY: Can walk (with or without aid)
                  • PARAPARETIC: Weak but some movement
                  • PARAPLEGIC: Complete paralysis
                  • Ambulatory status is strongest predictor of outcome
                  • Duration of deficit also important (<48h better)
                  1. ◆

                     Decision

                     Surgical Candidate Assessment

                     Multidisciplinary spine surgery evaluation

                     • CONSIDER SURGERY IF:
                     • • Single level compression
                     • • Spinal instability
                     • • Unknown primary (tissue diagnosis needed)
                     • • Radioresistant tumor (renal, melanoma, sarcoma)
                     • • Prognosis >3-6 months
                     • • Good performance status (ECOG 0-2)
                     • CONTRAINDICATIONS:
                     • • Complete paraplegia >48h
                     • • Multiple comorbidities
                     • • Very short prognosis
                     1. ●

                        Action

                        Surgical Decompression

                        Decompressive laminectomy ± stabilization

                        • Ideally within 24-48 hours
                        • Posterior approach most common
                        • Stabilization if instability present
                        • Follow with postoperative radiation
                        • Patchell trial: Surgery + RT > RT alone for selected pts
                        1. ●

                           Action

                           Supportive Care & Rehabilitation

                           Essential for all MSCC patients

                           • VTE prophylaxis (high risk)
                           • Bladder care (catheter if retention)
                           • Bowel regimen
                           • Pressure ulcer prevention
                           • Early physiotherapy
                           • Occupational therapy assessment
                           • Pain management
                           1. ●

                              Action

                              Steroid Taper

                              Begin after treatment initiated

                              • Start taper after RT started or surgery
                              • Taper over 1-2 weeks if neurologically stable
                              • Faster taper if significant side effects
                              • May need maintenance dose if symptoms recur
                              • Monitor for adrenal insufficiency if prolonged
                           2. ⚠

                              Warning

                              ⚠️ Poor Prognosis / Comfort Care

                              If very short life expectancy or complete deficits >48h

                              • Complete paraplegia >48h: <5% chance of walking again
                              • Focus on comfort and symptom control
                              • Pain management priority
                              • May still consider single fraction RT for pain
                              • Palliative care involvement
                     2. ●

                        Action

                        Radiotherapy

                        Primary or postoperative treatment

                        • Start within 24 hours if possible
                        • FRACTIONATION (2024 RCR guidance):
                        • • Prognosis <6 months: 8 Gy single fraction
                        • • Prognosis ≥6 months + ambulatory: 20 Gy/5 fx or 30 Gy/10 fx
                        • • Post-surgery: typically fractionated
                        • SBRT for reirradiation or oligometastatic disease
                  2. ●

                     Action

                     Radiosensitive Tumors

                     RT often preferred as primary treatment

                     • VERY RADIOSENSITIVE:
                     • • Myeloma, Lymphoma
                     • • Small cell lung cancer
                     • • Germ cell tumors
                     • May respond rapidly to RT alone
                     • Surgery rarely needed unless instability